Related references
Note: Only part of the references are listed.Malignancies in Juvenile Idiopathic Arthritis: A Preliminary Report
Sasha Bernatsky et al.
JOURNAL OF RHEUMATOLOGY (2011)
Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: diagnostic pitfall and association with survival
Ram Kumar Marwaha et al.
ANNALS OF HEMATOLOGY (2010)
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
Nicolino Ruperto et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Should the Food and Drug Administration Warning of Malignancy in Children Receiving Tumor Necrosis Factor α Blockers Change the Way We Treat Children With Juvenile Idiopathic Arthritis?
Thomas J. A. Lehman
ARTHRITIS AND RHEUMATISM (2010)
Juvenile Idiopathic Arthritis and Risk of Cancer A Nationwide Cohort Study
J. F. Simard et al.
ARTHRITIS AND RHEUMATISM (2010)
Tumor Necrosis Factor α Blockers and Malignancy in Children Forty-Eight Cases Reported to the Food and Drug Administration
Peter Diak et al.
ARTHRITIS AND RHEUMATISM (2010)
Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
Randy Q. Cron et al.
PEDIATRIC RHEUMATOLOGY (2010)
Monitoring the Long-Term Safety of Therapies for Children With Juvenile Idiopathic Arthritis: Time for a Consolidated Patient Registry
Meredith Y. Smith et al.
ARTHRITIS CARE & RESEARCH (2010)
Anti-Tumor Necrosis Factor Therapy and Cancer Risk in Patients With Autoimmune Disorders
Karen B. Onel et al.
ARTHRITIS CARE & RESEARCH (2010)
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
F. H. M. Prince et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor α Therapies Does the Risk Change With the Time Since Start of Treatment?
Johan Askling et al.
ARTHRITIS AND RHEUMATISM (2009)
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
Allison L. Smitten et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Biologic treatment of rheumatoid arthritis and the risk of malignancy - Analyses from a large US observational study
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2007)
Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis
Soko Setoguchi et al.
ARTHRITIS AND RHEUMATISM (2006)
A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis
OY Jones et al.
PEDIATRICS (2006)
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
E Baecklund et al.
ARTHRITIS AND RHEUMATISM (2006)
Cancer incidence in a general population of asthma patients
A González-Pérez et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Under-reporting of adverse drug reactions - A systematic review
Lorna Hazell et al.
DRUG SAFETY (2006)
A review of uses of health care utilization databases for epidemiologic research on therapeutics
S Schneeweiss et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
The German etanercept registry for treatment of juvenile idiopathic arthritis
G Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Polyarticular juvenile idiopathic arthritis treated with methotrexate complicate by the development of non-Hodgkin's lymphoma
AG Cleary et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2002)
Quality of care for patients with rheumatoid arthritis
CH MacLean et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Etanercept in children with polyarticular juvenile rheumatoid arthritis.
DJ Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)